Over 35,000 Cannabis Studies in a Decade: What Questions Remain?

In the past decade, scientists have published more than 35,000 cannabis studies, according to a new analysis by NORML. This impressive number of publications underscores the enormous interest of researchers in the subject, especially in the context of cannabis’ therapeutic uses, its health effects and the social and economic consequences of legalization.

Cannabis studies developments

Since 2014, more than 35,000 cannabis studies have been published. This is 70% of all publications on the subject since 1840. What’s more, 2022 was a record year in terms of the number of cannabis studies, with more than 4,300 published. These data clearly show that scientific interest in cannabis has reached an unprecedented level.

NORML’s analysis is based on searches of PubMed, one of the world’s leading sources of scientific publications. In total, more than 49,500 cannabis studies have been published in PubMed since 1840 , making it one of the most actively researched topics in biomedical science.

Key research areas

Therapeutic uses of cannabis
Research into the therapeutic uses of cannabis provides increasing evidence of its potential in treating a variety of conditions:

Pain Reduction : In many cases, cannabis has been shown to be as effective as morphine in relieving pain, but without the risk of addiction that comes with opioids.
Improved quality of life : Patients with autism, epilepsy, and other conditions resistant to traditional therapies have reported significant improvements in their quality of life with medical cannabis.

The Impact of Legalization on Society

Legalizing cannabis brings not only health benefits, but also social benefits:

Reduction in opioid overdoses : States that have legalized cannabis have seen fewer opioid overdoses.
Decreased opioid prescribing : Inclusion of cannabis in prescription monitoring programs has been shown to reduce the use of narcotic pain relievers.

Research on the chemical components of cannabis

There is increasing attention being paid to cannabis components other than THC and CBD :

Lesser-known cannabinoids: Research on cannabigerol ( CBG ) has shown its potential in treating cancer, metabolic disorders, and inflammatory diseases.
The role of terpenes: For example, D-limonene, a terpene with a citrus aroma, can relieve anxiety and paranoia caused by THC.
Synergistic effect: Interactions between cannabinoids, terpenes, and flavonoids can significantly enhance the therapeutic effects of cannabis.

In the past decade, cannabis research has yielded breakthroughs that have the potential to change medicine and the way we view the plant. One of the most promising areas is the lesser-known cannabinoids , such as cannabigerol (CBG). Scientists have discovered that CBG can act as an effective drug in treating cancer, metabolic disorders, and inflammatory diseases.

Terpenes, or aromatic chemical compounds present in cannabis, have also become an important topic of research. D-limonene, which has been shown to alleviate anxiety and paranoia caused by THC, has attracted particular interest. Cannabis studies suggest that terpenes can modulate the effects of THC, allowing for more balanced therapeutic effects.

In addition, scientists are increasingly understanding the so-called synergy effect, which emphasizes the importance of interactions between cannabinoids, terpenes, and flavonoids. It is these complex relationships that can maximize the therapeutic effectiveness of cannabis, and their full understanding opens the door to precision therapies.

Conclusions from NORML cannabis studies

NORML’s analysis debunks the myth that cannabis has not been adequately studied. In fact, research conducted over the past decade has significantly expanded our understanding of the plant and its medical potential. The results provide a solid basis for an informed policy debate based on facts, not prejudice.

Scientific cannabis studies have already influenced policy changes in many countries, providing arguments for the legalization of cannabis and its introduction into health care systems. At the same time, research results indicate the need for further investment in science to fully understand the therapeutic potential of cannabis and use its components in the most effective way.

Summary

The rapid growth of cannabis studies over the past decade is evidence of the growing interest of scientists in this plant. More than 35,000 studies have not only changed our understanding of cannabis, but also provided solid arguments for changing the political approach to its legalization.

The key postulate is to conduct evidence-based discussions that take into account the enormous therapeutic potential of cannabis. These cannabis studies are the key to understanding how cannabis can become an effective tool in medicine and an important element of the economy of the future.

__

(Featured image by  GRAS GRUN via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in FaktyKonopne. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us